Skip to content

Charles River Laboratories CRL Interest Paid, Excluding Capitalized Interest, Operating Activity

Interest Paid, Excluding Capitalized Interest, Operating Activity at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
Plexus logo
PlexusPLXS

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's interest paid, excluding capitalized interest, operating activity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's interest paid, excluding capitalized interest, operating activity?
Charles River Laboratories (CRL) reported interest paid, excluding capitalized interest, operating activity of $28.99M in Q1 2026.
How has Charles River Laboratories's interest paid, excluding capitalized interest, operating activity changed year-over-year?
Charles River Laboratories's interest paid, excluding capitalized interest, operating activity decreased by 0.3% year-over-year, from $29.09M to $28.99M.
What is the long-term trend for Charles River Laboratories's interest paid, excluding capitalized interest, operating activity?
Over 4 years (2021 to 2025), Charles River Laboratories's interest paid, excluding capitalized interest, operating activity has grown at a 9.5% compound annual growth rate (CAGR), from $70.78M to $101.72M.